SCHEMBL9574201

SCHEMBL9574201

ICCCC#CCOCCCCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
IDO1 P14902 1/20 0.39
NAAA Q02083 1/20 0.38
DRD2 P14416 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAOA P21397 1/20 0.37
FFAR1 O14842 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9574219 0.85 TDP1 (0.41) TDP1L3MBTL1IDO1NAAADRD2
SCHEMBL9763680 0.83 TDP1 (0.42) TDP1L3MBTL1IDO1NAAADRD2
SCHEMBL9763493 0.83 TDP1 (0.46) TDP1L3MBTL1IDO1NAAADRD2
SCHEMBL9763224 0.80 TDP1 (0.44) TDP1L3MBTL1IDO1NAAADRD2
SCHEMBL9763645 0.80 TDP1 (0.44) TDP1L3MBTL1IDO1NAAADRD2
SCHEMBL19423126 0.79 TDP1 (0.53) TDP1L3MBTL1ALDH1A1HPGDALOX15
SCHEMBL9763611 0.77 ALDH1A1 (0.49) ALDH1A1FFAR1
SCHEMBL9468938 0.77 TDP1 (0.43) TDP1L3MBTL1ALDH1A1MAOB
SCHEMBL198056 0.74 IDO1 (0.58) TDP1L3MBTL1IDO1SIGMAR1MEN1
SCHEMBL9574242 0.74 TDP1 (0.47) TDP1L3MBTL1IDO1NAAASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5243076-A Adrenergic stimulant intermediates GLAXO GROUP LTD. 1993-09-07 US disclosed
US-5225445-A Respiratory system disorders GLAXO GROUP LTD. 1993-07-06 US disclosed
US-5126375-A Asthma, chronic bronchitis GLAXO GROUP LTD. (GB) 1992-06-30 US disclosed
US-5091422-A Treating inflammatory or allergic skin disease, lowering gastric acidity GLAXO GROUP LIMITED (GB) 1992-02-25 US disclosed
US-4992474-A Adrenergic stimulants GLAXO GROUP LTD. (GB) 1991-02-12 US disclosed
US-4853381-A Ethanolamine compounds GLAXO GROUP LIMITED (GB) 1989-08-01 US disclosed
EP-0223410-A2 Ethanolamine Derivatives GLAXO GROUP LIMITED (GB) 1987-05-27 EP disclosed